ArticleScience translational medicine2019

TGF-β type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis.

Tieshi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.